Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.
William S ChenEric L FengRahul AggarwalAdam FoyeTomasz M BeerJoshi J AlumkalMartin GleaveKim N ChiRobert E ReiterMatthew B RettigChristopher P EvansEric J SmallNima SharifiShuang G ZhaoPublished in: Prostate cancer and prostatic diseases (2019)
This study presents a comprehensive assessment of germline variants in androgen metabolism genes and highlights HSD3B1 polymorphisms as prognostic of OS after ADT and associated with an aggressive gene expression tumor profile in mCRPC.